Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis
Liver International · 2024-07 · 44 (7) · 1513-1525
DOI: 10.1111/liv.15925 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Liver International, online erschienen am 03.04.2024. Verfasst von Alessandro Mantovani und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Vero…. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Recent observational studies examining the association between Helicobacter pylori infection and the risk of metabolic dysfunction‐associated steatotic liver disease (MASLD) have reported conflicting results. We performed a meta‐analysis to quantify the magnitude of the association between H. pylori infection and the risk of MASLD.
Methods
We systematically searched three large electronic databases to identify eligible observational studies (published up to 30 November 2023) in which liver biopsy, imaging methods or blood‐based biomarkers/scores were used for diagnosing MASLD. Data from selected studies were extracted, and meta‐analysis was performed using common and random‐effects modelling. Statistical heterogeneity among published studies, subgroup analyses, meta‐regression analyses and publication bias were assessed.
Results
A total of 28 observational studies (24 cross‐sectional and 4 longitudinal studies) were identified, including 231 291 middle‐aged individuals of predominantly Asian ethnicity (~95%). Meta‐analysis of cross‐sectional studies showed that H. pylori infection was significantly associated with a small increase in the risk of prevalent MASLD ( n = 24 studies; random‐effects odds ratio 1.11, 95% CI 1.05–1.18; I 2 = 63%). Meta‐analysis of data from longitudinal studies showed that H. pylori infection was significantly associated with an increased risk of developing incident MASLD over a mean 5‐year follow‐up ( n = 4 studies; random‐effects odds ratio 1.20, 95%CI 1.08–1.33; I 2 = 44%). Sensitivity analyses did not modify these results. The funnel plot did not reveal any significant publication bias.
Conclusions
H. pylori infection is associated with a mildly increased risk of prevalent and incident MASLD. Further well‐designed prospective and mechanistic studies are required to better decipher the complex link between H. pylori infection and the risk of MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
- Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy.
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
- Precision Medicine-Biological Resource Center, Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milan, Italy.
- Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
- Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University Innsbruck, Innsbruck, Austria.
ORCID-Profile: Alessandro Mantovani, Luca Valenti, Giovanni Targher
Zitieren
APA
Mantovani, A., Lando, M. G., Borella, N., Scoccia, E., Pecoraro, B., Gobbi, F., Bisoffi, Z., Valenti, L., Tilg, H., Byrne, C. D., & Targher, G. (2024). Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis. Liver International, 44(7), 1513-1525. https://doi.org/10.1111/liv.15925
Vancouver
Mantovani A, Lando MG, Borella N, Scoccia E, Pecoraro B, Gobbi F, et al. Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis. Liver International. 2024;44(7):1513-1525. doi:10.1111/liv.15925
BibTeX
@article{Mantovani2024,
author = {Mantovani, Alessandro and Lando, Maria Giovanna and Borella, Nicolò and Scoccia, Enrico and Pecoraro, Barbara and Gobbi, Federico and Bisoffi, Zeno and Valenti, Luca and Tilg, Herbert and Byrne, Christopher D and Targher, Giovanni},
title = {Relationship between Helicobacter pylori infection and risk of metabolic dysfunction‐associated steatotic liver disease: An updated meta‐analysis},
journal = {Liver International},
year = {2024},
volume = {44},
number = {7},
pages = {1513--1525},
doi = {10.1111/liv.15925}
}
EUVIMED